halothane has been researched along with Glycogen Storage Disease Type I in 1 studies
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casson, H | 1 |
1 other study available for halothane and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
Anaesthesia for portocaval bypass in patients with metabolic diseases.
Topics: Anesthesia, General; Chemical Phenomena; Chemistry; Child; Child, Preschool; Enflurane; Female; Glyc | 1975 |